Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
WM-115 | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2653 | 212 | 0.6598 | 0.7324 | 0.0799 | 0.0776 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 9635 | 173 | 0.4953 | 0.4364 | 0.0180 | 0.0207 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 11677 | 368 | 0.7113 | 0.6866 | 0.0315 | 0.0312 |
COLO 858 | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1205 | 991 | 0.0254 | 0.0294 | 0.8224 | 0.8047 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 5747 | 125 | 0.2943 | 0.3050 | 0.0218 | 0.0212 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 16963 | 834 | 0.7730 | 0.8197 | 0.0492 | 0.0506 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 2328 | 167 | 0.1131 | 0.1190 | 0.0717 | 0.0733 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 4016 | 78 | 0.2061 | 0.2010 | 0.0194 | 0.0218 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 5745 | 285 | 0.3434 | 0.2974 | 0.0496 | 0.0491 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 1556 | 1484 | 0.0085 | 0.0082 | 0.9537 | 0.9545 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 3954 | 69 | 0.2034 | 0.1687 | 0.0175 | 0.0176 |
A-375 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 3389 | 65 | 0.1683 | 0.1709 | 0.0192 | 0.0246 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1638 | 157 | 0.0775 | 0.0717 | 0.0958 | 0.0989 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 4811 | 91 | 0.2471 | 0.2452 | 0.0189 | 0.0214 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 7134 | 125 | 0.4409 | 0.4477 | 0.0175 | 0.0178 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 3782 | 731 | 0.5059 | 0.4677 | 0.1933 | 0.1974 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 3302 | 117 | 0.1667 | 0.1598 | 0.0354 | 0.0325 |
A-375 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 9567 | 390 | 0.4398 | 0.4342 | 0.0408 | 0.0408 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2325 | 439 | 0.3128 | 0.3086 | 0.1888 | 0.1792 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2096 | 82 | 0.1054 | 0.1035 | 0.0391 | 0.0423 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 5860 | 137 | 0.3600 | 0.3831 | 0.0234 | 0.0229 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 2098 | 334 | 0.0923 | 0.0842 | 0.1592 | 0.1524 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1649 | 67 | 0.0828 | 0.0757 | 0.0406 | 0.0403 |
WM-115 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1782 | 333 | 0.3917 | 0.3790 | 0.1869 | 0.1994 |
WM-115 | Vemurafenib | PF562271 | 1.000 | 0.316 | uM | 72 | hr | 1 | 2021 | 347 | 0.4525 | 0.4481 | 0.1717 | 0.1607 |